Trial Profile

Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established After Controlled Ovarian Stimulation in Clinical Trial 38819 for Org 36286 (Corifollitropin Alfa)

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 04 Feb 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Corifollitropin alfa (Primary) ; Recombinant follicle-stimulating hormone
Indications Infertility
Focus Adverse reactions; Registrational
Sponsors Merck Sharp & Dohme; Organon

Most Recent Events

05 Jun 2019 This trial has been completed in United Kingdom, according to European Clinical Trials Database.
22 May 2019 This trial is completed in Belgium according to Eudra
18 Feb 2009 Actual end date (Aug 2008) added as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com